Cresanto Global Limited (BOM:531207)
4.220
0.00 (0.00%)
At close: Feb 12, 2026
Cresanto Global Revenue
Cresanto Global had revenue of 200.00K INR in the quarter ending December 31, 2025, with 132.56% growth. This brings the company's revenue in the last twelve months to 5.91M, up 6,774.42% year-over-year. In the fiscal year ending March 31, 2025, Cresanto Global had annual revenue of 5.26M.
Revenue (ttm)
5.91M
Revenue Growth
+6,774.42%
P/S Ratio
3.05
Revenue / Employee
1.18M
Employees
5
Market Cap
18.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.26M | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 206.32K | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 663.49M |
| Cian Healthcare | 232.80M |
| Fabino Enterprises | 204.36M |
| Beryl Drugs | 176.65M |
| Decipher Labs | 176.11M |
| Brawn Biotech | 168.03M |
| Unjha Formulations | 148.12M |
| Ganga Pharmaceuticals | 26.93M |